WallStSmart

Medical Properties Trust, Inc. (MPT)vsPrologis Inc (PLD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Prologis Inc generates 752% more annual revenue ($9.38B vs $1.10B). PLD leads profitability with a 39.7% profit margin vs -11.5%. MPT appears more attractively valued with a PEG of 1.61. PLD earns a higher WallStSmart Score of 63/100 (C+).

MPT

Buy

55

out of 100

Grade: C

Growth: 4.0Profit: 4.5Value: 4.7Quality: 4.5
Piotroski: 2/9Altman Z: 0.11

PLD

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 7.0Value: 5.3Quality: 4.0
Piotroski: 2/9Altman Z: 1.01
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MPT.

PLDUndervalued (+43.3%)

Margin of Safety

+43.3%

Fair Value

$254.85

Current Price

$144.54

$110.31 discount

UndervaluedFair: $254.85Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MPT2 strengths · Avg: 10.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Operating MarginProfitability
58.2%10/10

Strong operational efficiency at 58.2%

PLD6 strengths · Avg: 9.2/10
Profit MarginProfitability
39.7%10/10

Keeps 40 of every $100 in revenue as profit

Operating MarginProfitability
38.5%10/10

Strong operational efficiency at 38.5%

EPS GrowthGrowth
65.2%10/10

Earnings expanding 65.2% YoY

Market CapQuality
$130.91B9/10

Large-cap with strong market position

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.14B8/10

Generating 1.1B in free cash flow

Areas to Watch

MPT4 concerns · Avg: 3.3/10
PEG RatioValuation
1.614/10

Expensive relative to growth rate

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-2.7%2/10

ROE of -2.7% — below average capital efficiency

PLD4 concerns · Avg: 3.0/10
P/E RatioValuation
35.4x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
7.0%3/10

ROE of 7.0% — below average capital efficiency

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
108.142/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : MPT

The strongest argument for MPT centers on Price/Book, Operating Margin. Revenue growth of 12.6% demonstrates continued momentum.

Bull Case : PLD

The strongest argument for PLD centers on Profit Margin, Operating Margin, EPS Growth. Profitability is solid with margins at 39.7% and operating margin at 38.5%.

Bear Case : MPT

The primary concerns for MPT are PEG Ratio, EPS Growth, Piotroski F-Score. Debt-to-equity of 2.15 is elevated, increasing financial risk.

Bear Case : PLD

The primary concerns for PLD are P/E Ratio, Return on Equity, Piotroski F-Score.

Key Dynamics to Monitor

MPT profiles as a turnaround stock while PLD is a mature play — different risk/reward profiles.

MPT carries more volatility with a beta of 1.46 — expect wider price swings.

MPT is growing revenue faster at 12.6% — sustainability is the question.

PLD generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

PLD scores higher overall (63/100 vs 55/100), backed by strong 39.7% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medical Properties Trust, Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Medical Properties Trust, Inc. is a self-advised real estate investment trust to acquire and develop net-leased hospital facilities.

Prologis Inc

REAL ESTATE · REIT - INDUSTRIAL · USA

Prologis, Inc. is a real estate investment trust headquartered in San Francisco, California that invests in logistics facilities, with a focus on the consumption side of the global supply chain.

Want to dig deeper into these stocks?